The cancer antigen CA125 represents a novel counter receptor for galectin-1

Journal of Cell Science

Volumn 116, Issue 7, 2003, Pages 1305-1318

  Seelenmeyer, Claudia ^a   Wegehingel, Sabine ^a   Lechner, Johannes ^a   Nickel, Walter ^a  

^a Bio chemie Zentrum Heidelberg   (Germany)

Author keywords

CA125; Cell surface expression; Counter receptor; Galectin; Nonclassical export; Tumor antigen

Indexed keywords

CA 125 ANTIGEN; GALAPTIN; GALECTIN 1; GALECTIN 3; LECTIN RECEPTOR; SIGNAL PEPTIDE; TUMOR ANTIGEN;

ANIMAL CELL; APOPTOSIS; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL LYSATE; CELL MEMBRANE; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; EXTRACELLULAR MATRIX; FLUORESCENCE ACTIVATED CELL SORTING; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOLOGICAL PROCEDURES; INTRACELLULAR TRANSPORT; MASS SPECTROMETRY; MEMBRANE BINDING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW; TUMOR GROWTH;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, SURFACE; BINDING SITES; CA-125 ANTIGEN; CELL MEMBRANE; CHO CELLS; CRICETINAE; GALECTIN 1; GALECTIN 3; HELA CELLS; HUMANS; NEOPLASMS; OLIGOSACCHARIDES, BRANCHED-CHAIN; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECEPTORS, CELL SURFACE;

ANIMALIA;

EID: 0037383703     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.00312     Document Type: Review

References (51)

1. Albritton, L. M., Tseng, L., Scadden, D. and Cunningham, J. M. (1989). A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 57, 659-666.
2. Armstrong, S. A., Staunton, J. E., Silverman, L. B., Pieters, R., den Boer, M. L., Minden, M. D., Sallan, S. E., Lander, E. S., Golub, T. R. and Korsmeyer, S. J. (2002). MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat. Genet. 30, 41-47.
3. Balch, W. E. and Rothman, J. E. (1985). Characterization of protein transport between successive compartments of the Golgi apparatus: asymmetric properties of donor and acceptor activities in a cell-free system. Arch. Biochem. Biophys. 240, 413-425.
4. Barondes, S. H., Cooper, D. N., Gitt, M. A. and Leffler, H. (1994). Galectins. Structure and function of a large family of animal lectins. J. Biol. Chem. 269, 20807-20810.
5. Bast, R. C., Jr, Feeney, M., Lazarus, H., Nadler, L. M., Colvin, R. B. and Knapp, R. C. (1981). Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin. Invest. 68, 1331-1337.
6. Bast, R. C., Jr, Klug, T. L., St John, E., Jenison, E., Niloff, J. M., Lazarus, H., Berkowitz, R. S., Leavitt, T., Griffiths, C. T., Parker, L. et al. (1983). A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N. Engl. J. Med. 309, 883-887.
7. Bon, G. G., Kenemans, P., Verstraeten, R., van Kamp, G. J. and Hilgers, J. (1996). Serum tumor marker immunoassays in gynecologic oncology: establishment of reference values. Am. J. Obstet. Gynecol. 174, 107-114.
8. Bresalier, R. S., Byrd, J. C., Wang, L. and Raz, A. (1996). Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3. Cancer Res. 56, 4354-4357.
9. Cho, M. and Cummings, R. D. (1995). Galectin-1, a β-galactoside-binding lectin in Chinese hamster ovary cells. II. Localization and biosynthesis. J. Biol. Chem. 270, 5207-5212.
10. Cleves, A. E. (1997). Protein transports: the nonclassical ins and outs. Curr. Biol. 7, R318-320.
11. Cleves, A. E., Cooper, D. N., Barondes, S. H. and Kelly, R. B. (1996). A new pathway for protein export in Saccharomyces cerevisiae. J. Cell Biol. 133, 1017-1026.
12. Cooper, D. N. and Barondes, S. H. (1990). Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism. J. Cell Biol. 110, 1681-1691.
13. Davey, R. A., Hamson, C. A., Healey, J. J. and Cunningham, J. M. (1997). In vitro binding of purified marine ecotropic retrovirus envelope surface protein to its receptor, MCAT-1. J. Virol. 71, 8096-8102.
14. Davis, H. M., Zurawski, V. R., Jr, Bast, R. C., Jr and Klug, T. L. (1986). Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas. Cancer Res. 46, 6143-6148.
15. Deutscher, S. L. and Hirschberg, C. B. (1986). Mechanism of galactosylation in the Golgi apparatus. A Chinese hamster ovary cell mutant deticient in translocation of UDP-galactose across Golgi vesicle membranes. J. Biol. Chem. 261, 96-100.
16. Engling, A., Backhaus, R., Stegmayer, C., Zehe, C., Seelenmeyer, C., Kehlenbach, A., Schwappach, B., Wegehingel, S. and Nickel, W. (2002). Biosynthetic FGF-2 is targeted to non-lipid raft microdomains following translocation to the extracellular surface of CHO cells. J. Cell Sci. 115, 3619-3631.
17. Fendrick, J. L., Konishi, I., Geary, S. M., Parmley, T. H., Quirk, J. G., Jr and O'Brien, T. J. (1997). CA125 phosphorylation is associated with its secretion from the WISH human amnion cell line. Tumour Biol. 18, 278-289.
18. Füllekrug, J., Sönnichsen, B., Schafer, V., Nguyen Van, P., Söling, H. D. and Mieskes, G. (1997). Characterization of brefeldin A induced vesicular structures containing cycling proteins of the intermediate compartment/cis-Golgi network. FEBS Lett. 404, 75-81.
19. Füillekrug, J., Suganuma, T., Tang, B. L., Hong, W., Storrie, B. and Nilsson, T. (1999). Localization and recycling of gp27 (hp24gamma3): complex formation with other p24 family members. Mol. Biol. Cell 10, 1939-1955.
20. Gey, G. O., Coffman, W. D. and Kubicek, M. T. (1952). Tissue culture studies of the prolieferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12, 264-265.
21. Hardardottir, H., Parmley, T., Quirk, J., Sanders, M., Miller, F. and O'Brien, T. (1990). Distribution of CA125 in embryonic tissue and adult derivatives of the fetal periderm. Am. J. Obstet. Gynecol. 163, 1925-1931.
22. Hughes, R. C. (1997). The galectin family of mammalian carbohydrate-binding molecules. Biochem. Soc. Trans. 25, 1194-1198.
23. Hughes, R. C. (1999). Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim. Biophys. Acta 1473, 172-185.
24. Iurisci, I., Tinari, N., Natoli, C., Angelucci, D., Cianchetti, E. and Iacobelli, S. (2000). Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin. Cancer Res. 6, 1389-1393.
25. Jenne, N., Frey, K., Brugger, B. and Wieland, F. T. (2002). Oligomeric state and stoichiometry of p24-proteins in the early secretory pathway. J. Biol. Chem. 277, 46504-46511.
26. Kutay, U., Ahnert-Hilger, G., Hartmann, E., Wiedenmann, B. and Rapoport, T. A. (1995). Transport route for synaptobrevin via a novel pathway of insertion into the endoplasmic reticulum membrane. EMBO J. 14, 217-223.
27. Lahm, H., Andre, S., Hoeflich, A., Fischer, J. R., Sordat, B., Kaltner, H., Wolf, E. and Gabius, H. J. (2001). Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J. Cancer Res. Clin. Oncol. 127, 375-386.
28. Lewis, M. J. and Pelham, H. R. (1990). A human homologue of the yeast HDEL receptor. Nature 348, 162-163.
29. Lewis, M. J. and Pelham, H. R. (1992). Ligand-induced redistribution of a human KDEL receptor from the Golgi complex to the endoplasmic reticulum. Cell 68, 353-364.
30. Lippincott-Schwartz, J., Yuan, L. C., Bonifacino, J. S. and Klausner, R. D. (1989). Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell 56, 801-813.
31. Lloyd, K. O. and Yin, B. W. (2001). Synthesis and secretion of the ovarian cancer antigen CA 125 by the human cancer cell line NIH:OVCAR-3. Tumour Biol. 22, 77-82.
32. Lloyd, K. O., Yin, B. W. and Kudryashov, V. (1997). Isolation and characterization of ovarian cancer antigen CA 125 using a new monoclonal antibody (VK-8): identification as a mucin-type molecule. Int. J. Cancer 71, 842-850.
33. Lloyd, R. V. (2001). Distinguishing benign from malignant thyroid lesions: galectin 3 as the latest candidate. Endocr. Pathol. 12, 255-257.
34. Lutomski, D., Fouillit, M., Bourin, P., Mellottee, D., Denize, N., Pontet, M., Bladier, D., Caron, M. and Joubert-Caron, R. (1997). Externalization and binding of galectin-1 on cell surface of K562 cells upon erythroid differentiation. Glycobiology 7, 1193-1199.
35. Meyer, T. and Rustin, G. J. (2000). Role of tumour markers in monitoring epithelial ovarian cancer. Br. J. Cancer 82, 1535-1538.
36. Nagata, A., Hirota, N., Sakai, T., Fujimoto, M. and Komoda, T. (1991). Molecular nature and possible presence of a membranous glycan-phosphatidylinositol anchor of CA125 antigen. Tumour Biol. 12, 279-286.
37. Nap, M., Vitali, A., Nustad, K., Bast, R. C., Jr, O'Brien, T. J., Nilsson, O., Seguin, P., Suresh, M. R., Bormer, O. P., Saga, T. et al. (1996). Immunohistochemical characterization of 22 monoclonal antibodies against the CA125 antigen: 2nd report from the ISOBM TD-1 Workshop. Tumour Biol. 17, 325-331.
38. Nguyen, J. T., Evans, D. P., Galvan, M., Pace, K. E., Leitenberg, D., Bui, T. N. and Baum, L. G. (2001). CD45 modulates galectin-1-induced T cell death: regulation by expression of core 2 O-glycans. J. Immunol. 167, 5697-5707.
39. O'Brien, T., Hardin, J., Bannon, G., Norris, J. and Quirk, J. (1986). CA125 antigen in human amniotic fluid and fetal membranes. Am. J. Obstet. Gynecol. 155, 50-55.
40. O'Brien, T. J., Beard, J. B., Underwood, L. J., Dennis, R. A., Santin, A. D. and York, L. (2001). The CA 125 gene: an extracellular superstructure dominated by repeat sequences. Tumour Biol. 22, 348-366.
41. Orci, L., Tagaya, M., Amherdt, M., Perrelet, A., Donaldson, J. G., Lippincott-Schwartz, J., Klausner, R. D. and Rothman, J. E. (1991). Brefeldin A, a drug that blocks secretion, prevents the assembly of non-clathrin-coated buds on Golgi cisternae. Cell 64, 1183-1195.
42. Perillo, N. L., Pace, K. E., Seilhamer, J. J. and Baum, L. G. (1995). Apoptosis of T cells mediated by galectin-1. Nature 378, 736-739.
43. Perillo, N. L., Marcus, M. E. and Baum, L. G. (1998). Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J. Mol. Med. 76, 402-412.
44. Puck, T. T., Cieciura, S. J. and Robinson, A. (1958). Genetics of somatic mammalian cells. J. Mol. Med. 108, 945-955.
45. Rabinovich, G. A., Baum, L. G., Tinari, N., Paganelli, R., Natoli, C., Liu, F. T. and Iacobelli, S. (2002). Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol. 23, 313-320.
46. Scherer, W. F., Syverton, J. T. and Gey, G. O. (1953). Studies on the propagation in vitro of poliomyelitis viruses. J. Exp. Med. 97, 695-710.
47. Sönnichsen, B., Füllekrug, J., Nguyen Van, P., Diekmann, W., Robinson, D. G. and Mieskes, G. (1994). Retention and retrieval: both mechanisms cooperate to maintain calreticulin in the endoplasmic reticulum. J. Cell Sci. 107, 2705-2717.
48. Urlinger, S., Baron, U., Thellmann, M., Hasan, M. T., Bujard, H. and Hillen, W. (2000). Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc. Natl. Acad. Sci. USA 97, 7963-7968.
49. Wilm, M., Shevchenko, A., Houthaeve, T., Breit, S., Schweigerer, L., Fotsis, T. and Mann, M. (1996). Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature 379, 466-469.
50. Yin, B. W. and Lloyd, K. O. (2001). Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. J. Biol. Chem. 276, 27371-27375.
51. Zurawski, V., Davis, H., Finkler, N., Harrison, C., Bast, R. and Knapp, R. (1988). Tissue distribution and characteristics of the CA125 antigen. Cancer Rev. 11-12, 102-118.